Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Spire

Showing results (161-170 of 335) with videos related to

Pageof 34
Sort By:
HIV Clinical Trials|December 4, 2010
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)Thomas Boulet, Juliette Pavie, Isabelle Charreau, et al.
Antiviral Therapy|March 9, 2005
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapyAnne-Déborah Bouhnik, Marie Préau, Emmanuelle Vincent, et al.
Therapeutic Drug Monitoring|January 25, 2005
Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohortXavier Duval, France Mentré, Claire Lamotte, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2003
Health-related quality of life after 1 year of highly active antiretroviral therapyPatrizia Carrieri, Bruno Spire, Ségolène Duran, et al.
BMC Health Services Research|November 6, 2025
Exploring individual and structural factors influencing healthcare seeking behavior in the context of the Senegal's Universal Health Coverage program: a multilevel analysis from the ANRS-12399 Soignants Sénégal studyOusmane Diop, El Hadji Ba, Gwenaëlle Maradan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2014
High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohortFabienne Marcellin, Perrine Roux, Marc-Arthur Loko, et al.
Medical Care|February 25, 2012
Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationshipKarine Lamiraud, Jean-Paul Moatti, François Raffi, et al.
Plos One|June 16, 2012
Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trialGilbert Ndziessi, Sylvie Boyer, Charles Kouanfack, et al.
AIDS Care|February 6, 2024
High PrEP acceptability and need for tailored implementation in Cambodian key populations: results from a qualitative assessmentCamilla Oliveri, Rothmony Eang, Olivier Ségéral, et al.
Antiviral Therapy|February 6, 2004
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up studyMaria Patrizia Carrieri, François Raffi, Charlotte Lewden, et al.
Pageof 34

Showing results (161-170 of 335) with videos related to

Sort By:
Pageof 34
HIV Clinical Trials|December 4, 2010
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)Thomas Boulet, Juliette Pavie, Isabelle Charreau, et al.
Antiviral Therapy|March 9, 2005
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapyAnne-Déborah Bouhnik, Marie Préau, Emmanuelle Vincent, et al.
Therapeutic Drug Monitoring|January 25, 2005
Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohortXavier Duval, France Mentré, Claire Lamotte, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2003
Health-related quality of life after 1 year of highly active antiretroviral therapyPatrizia Carrieri, Bruno Spire, Ségolène Duran, et al.
BMC Health Services Research|November 6, 2025
Exploring individual and structural factors influencing healthcare seeking behavior in the context of the Senegal's Universal Health Coverage program: a multilevel analysis from the ANRS-12399 Soignants Sénégal studyOusmane Diop, El Hadji Ba, Gwenaëlle Maradan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2014
High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohortFabienne Marcellin, Perrine Roux, Marc-Arthur Loko, et al.
Medical Care|February 25, 2012
Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationshipKarine Lamiraud, Jean-Paul Moatti, François Raffi, et al.
Plos One|June 16, 2012
Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trialGilbert Ndziessi, Sylvie Boyer, Charles Kouanfack, et al.
AIDS Care|February 6, 2024
High PrEP acceptability and need for tailored implementation in Cambodian key populations: results from a qualitative assessmentCamilla Oliveri, Rothmony Eang, Olivier Ségéral, et al.
Antiviral Therapy|February 6, 2004
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up studyMaria Patrizia Carrieri, François Raffi, Charlotte Lewden, et al.
Pageof 34